Summary
The product Mesterolone 25 mg, manufactured by Unique Pharma, was independently tested to confirm its composition and dosage accuracy. The batch number GH65721K, submitted by reseller Opitropin.EU, underwent qualitative and quantitative analysis by Janoshik Analytical, a well-known laboratory specializing in pharmaceutical testing.
The results indicate the presence of Mesterolone, with a measured concentration of 19.71 mg per pill, which is below the expected dosage of 25 mg. This deviation of approximately 21% underdose highlights potential inconsistencies in the product’s formulation.
The sample was ordered on 1 August 2022, received on 9 August 2022, and the analysis was conducted on 12 August 2022.
This report serves as an educational resource, encouraging harm reduction practices and informed decision-making within the community. It is crucial to consider that reseller-submitted samples may not fully reflect the consistency of products available on the market.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: Mesterolone (Proviron)
- Declared Dosage: 25 mg per pill
- Batch Number: GH65721K
- Expiration Date: Not provided
- Delivery Method: Oral (pill)
Sample Acquisition and Testing
- Task Number: #22610
- Testing Ordered: 1 August 2022
- Sample Received: 9 August 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specifications: 25 mg per pill
- Measured Concentration: 19.71 mg per pill
- Accuracy: 78.84%
Verification Details
- Verification URL: https://janoshik.com/tests/22610_AUWYJJVU9EKY
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
While the test confirms the presence of Mesterolone, the detected dosage of 19.71 mg is lower than the claimed 25 mg, suggesting potential quality control issues in production. Consumers should be cautious and consider additional independent testing to ensure consistency across batches.
Conclusion
The analysis verifies the presence of Mesterolone (Proviron) but highlights a notable underdose of around 21%, indicating inconsistencies in formulation. Buyers are advised to remain informed and cautious when sourcing such products.
This report is provided to support educational initiatives and harm reduction efforts within the community.
Disclaimer
This report is for educational and harm reduction purposes only. Independent testing of multiple batches is recommended to ensure product consistency.
